Related references
Note: Only part of the references are listed.Surgical Treatments of Hepatobiliary Cancers
Ganesh Gunasekaran et al.
HEPATOLOGY (2021)
Liver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice
Dhwanil A. Dalwadi et al.
MOLECULAR THERAPY (2021)
Ultra-small lipid nanoparticles encapsulating sorafenib and midkine-siRNA selectively-eradicate sorafenib-resistant hepatocellular carcinoma in vivo
Mahmoud A. Younis et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Late presentation of hepatocellular carcinoma highlights the need for a public health programme to eliminate hepatitis B
Richard Nhlane et al.
LANCET (2021)
Targeted delivery of siRNAs against hepatocellular carcinoma-related genes by a galactosylated polyaspartamide copolymer
Francesca Perrone et al.
JOURNAL OF CONTROLLED RELEASE (2021)
An AAV gene therapy computes over multiple cellular inputs to enable precise targeting of multifocal hepatocellular carcinoma in mice
Bartolomeo Angelici et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Cure the Incurable? Recent Breakthroughs in Immune Checkpoint Blockade for Hepatocellular Carcinoma
Pei-Yi Chu et al.
CANCERS (2021)
Liver gene therapy and hepatocellular carcinoma: A complex web
Ype P. de Jong et al.
MOLECULAR THERAPY (2021)
Hepatocellular Carcinoma - Origins and Outcomes
Robin K. Kelley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma
Fan-Hua Kong et al.
THERANOSTICS (2021)
Scientific Rationale for Combined Immunotherapy with PD-1/PD-L1 Antibodies and VEGF Inhibitors in Advanced Hepatocellular Carcinoma
Masatoshi Kudo
CANCERS (2020)
Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial
Roser Pinyol et al.
GUT (2019)
Systemic Management for Advanced Hepatocellular Carcinoma: A Review of the Molecular Pathways of Carcinogenesis, Current and Emerging Therapies, and Novel Treatment Strategies
Saad Saffo et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
Is there a place for Ramucirumab after Sorafenib in patients with advanced HCC?
Yeo Jeong So et al.
HEPATOBILIARY SURGERY AND NUTRITION (2019)
Challenges and Opportunities in the Clinical Development of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma
Michael J. Flynn et al.
HEPATOLOGY (2019)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
A multifunctional nanocarrier for efficient TRAIL-based gene therapy against hepatocellular carcinoma with desmoplasia in mice
Chun-Hung Liu et al.
HEPATOLOGY (2018)
Nanomedicines reveal how PBOV1 promotes hepatocellular carcinoma for effective gene therapy
Yu Guo et al.
NATURE COMMUNICATIONS (2018)
CDK4/6 inhibition and sorafenib: a menage a deux in HCC therapy?
Diego Calvisi et al.
GUT (2017)
Aptamer-mediated gene therapy enhanced antitumor activity against human hepatocellular carcinoma in vitro and in vivo
Shuangli Xiao et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Enhanced Nanodrug Delivery to Solid Tumors Based on a Tumor Vasculature-Targeted Strategy
Chenghua Song et al.
ADVANCED FUNCTIONAL MATERIALS (2016)
Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)aEuro
D. Koeberle et al.
ANNALS OF ONCOLOGY (2016)
Carboxymethyl Chitosan-Modified Polyamidoamine Dendrimer Enables Progressive Drug Targeting of Tumors via pH-Sensitive Charge Inversion
Xiaole Qi et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2016)
IMMUNOTHERAPY PD-1 says goodbye, TIM-3 says hello
Diana Romero
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Multilayer-Coated Liquid Crystalline Nanoparticles for Effective Sorafenib Delivery to Hepatocellular Carcinoma
Raj Kumar Thapa et al.
ACS APPLIED MATERIALS & INTERFACES (2015)
Combination of Nanoparticle-Delivered siRNA for Astrocyte Elevated Gene-1 (AEG-1) and All-trans Retinoic Acid (ATRA): An Effective Therapeutic Strategy for Hepatocellular Carcinoma (HCC)
Devaraja Rajasekaran et al.
BIOCONJUGATE CHEMISTRY (2015)
Nanoassemblies Based on Supramolecular Complexes of Nonionic Amphiphilic Cyclodextrin and Sorafenib as Effective Weapons to Kill Human HCC Cells
Maria Luisa Bondi et al.
BIOMACROMOLECULES (2015)
Tim-3 fosters HCC development by enhancing TGF-β-mediated alternative activation of macrophages
Wenjiang Yan et al.
GUT (2015)
Targeting exosomal miRNA with pH-sensitive liposome coated chitosan-siRNA nanoparticles for inhibition of hepatocellular carcinoma metastasis
Na Wu et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Synergistic inhibition of breast cancer by co-delivery of VEGF siRNA and paclitaxel via vapreotide-modified core-shell nanoparticles
Qiang Feng et al.
BIOMATERIALS (2014)
pH-Sensitive Self-Assembled Carboxymethyl Chitosan-Modified DNA/Polyethylenimine Complexes for Efficient Gene Delivery
Fengxi Liu et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2014)
Nanoparticle-formulated siRNA targeting integrins inhibits hepatocellular carcinoma progression in mice
Roman L. Bogorad et al.
NATURE COMMUNICATIONS (2014)
Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma
Hang Li et al.
HEPATOLOGY (2012)
pH-sensitive drug loading/releasing in amphiphilic copolymer PAE-PEG: Integrating molecular dynamics and dissipative particle dynamics simulations
Zhonglin Luo et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly (β-amino ester) block copolymer micelles for cancer therapy
Jinyoung Ko et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Combined endostatin/sFlt-1 antiangiogenic gene therapy is highly effective in a rat model of HCC
F Graepler et al.
HEPATOLOGY (2005)
Share Paper
